Respiratory Infections News

SEATTLE — An 8-week boosted regimen of bedaquiline and linezolid was noninferior to standard 24-week treatment for tuberculosis in terms of clinical outcomes, according to the results of a phase 2-3 trial.

One in 56 infants born healthy in Europe between July 2017 and April 2020 was hospitalized due to respiratory syncytial virus, or RSV, according to study results published in The Lancet Respiratory Medicine.

IL-6 receptor antagonists and antiplatelet agents improved chances for 6-month survival among patients with COVID-19, according to study results presented at Society of Critical Care Medicine’s Critical Care Congress and published in JAMA.

Compared with placebo, convalescent plasma with neutralizing

The FDA has accepted for priority review a supplemental biologics license application for Pfizer’s 20-valent pneumococcal conjugate vaccine for use in infants and children aged 6 weeks to 17 years, Pfizer announced.

Many patients with tuberculosis who were potentially eligible for a shorter 4-month therapy were treated with standard 6-month courses, according to a recent study.

Undernutrition, both before tuberculosis onset and at treatment initiation, as well as a lack of body mass index increase after intensive therapy, are associated with unfavorable TB outcomes, according to a recent study.

In children exposed to tuberculosis, chest radiography helped in detecting asymptomatic coprevalent TB and predicting incident TB after baseline, according to a study in American Journal of Respiratory and Critical Care Medicine.

Disruptions to care caused by the COVID-19 pandemic continued to negatively impact the fight against tuberculosis as cases and deaths have increased for the second year in a row after decades of declines, according to WHO’s 2022 Global TB Report.

Previous tuberculosis in Gambian children was significantly associated with impaired lung function and health-related quality of life, according to a cross-sectional comparative study published in Thorax.